Plain-English translation of NCT04641416 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This pilot study is testing a new way to monitor the heart function of patients who have received the HeartMate 3 — a magnetic blood pump that supports a failing heart. Researchers want to see if they can safely check how well your heart is working using noninvasive methods (like ultrasound) that the pump itself can provide, rather than requiring frequent uncomfortable procedures.
Patients with magnetic blood pumps currently need frequent time-consuming tests like ultrasounds and heart catheterizations to make sure their pump is working properly and not causing problems. This study aims to develop a simpler, less burdensome way to monitor your heart safely and frequently at home or during regular visits.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to use your HeartMate 3 pump's built-in monitoring capabilities to track your heart function. During visits to the Medical University of Vienna, doctors may adjust your pump speed slightly (by up to 20% from your current setting) while performing ultrasound scans to correlate what the pump is measuring with what the ultrasound shows. The study does not require you to take any new medications or undergo surgery — only to participate in monitoring sessions and testing.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Austria